Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Final Results

3rd Mar 2016 07:00

RNS Number : 8537Q
Exova Group PLC
03 March 2016
 

2015 FULL YEAR RESULTS ANNOUNCEMENT

3 March 2016

Exova Group plc ("Exova"), a leading international provider of technically demanding testing and advisory services announces its full year results for the year ended 31 December 2015.

Solid performance with strong revenue growth 

· Revenue up 9.9% at constant currency; 7.9% at actual rates

o 2.3% organic growth at constant currency demonstrating the benefit of diversification

o 7.6% growth from M&A activity

· 7.7% organic growth at constant currency excluding Oil & Gas and Industrials

· Eight M&A transactions completed with encouraging pipeline

· Proposed final dividend of 2.2p per share

 

Adjusted results1

 

 

 

2015

£m

 

 

 

2014

£m

 

 

 

Reported growth

 

Organic growth at constant currency

Growth from acquisitions net of disposals at constant currency

 

Revenue

296.5

274.9

7.9%

2.3%

7.6%

EBITA

46.7

46.2

1.1%

 

 

Profit before tax

40.4

39.82

1.5%

 

 

EBITA margin

15.8%

16.8%

 

 

 

Pro-forma earnings per share

12.2p

11.9p2

 

 

 

 

Statutory results3

2015

£m

2014

£m

Reported growth

 

Operating profit

29.5

19.6

50.5%

Profit / (loss) before tax

23.2

(23.7)

 

Earnings per share

6.8p

(16.6)p

 

Proposed final dividend per share

2.2p

2.0p

 

 

Notes:

1) Adjusted results is operating profit from continuing operations before separately disclosed items, 2014 management fee to private equity investor, interest and taxation.

2) 2014 pro-forma profit before tax and adjusted earnings per share have been calculated as if the post IPO capital and debt structure had been in place throughout that year.

3) Statutory results for 2014 reflect pre-IPO funding structure and IPO transaction costs.

 

Ian El-Mokadem, Chief Executive Officer, commented:

 

"We are pleased to have delivered results which are in line with our guidance, demonstrating the strength of our diversified business and our ability to respond to changing market conditions. We delivered strong overall growth, with solid organic performance enhanced by our most successful year to date for acquisitions. The Group expects to deliver modest organic growth at constant currency in 2016 due to the strength of our portfolio and model.

 

Our medium-term revenue expectation remains mid-single digit organic growth, supplemented by acquisitions."

 

 

 

Contacts

 

For further information please contact:

 

Ian Middleton, Powerscourt Group

Tel. Direct +44 (0)20 7549 0998 / +44 (0)7885 508 527

[email protected]

 

Sophie Moate, Powerscourt Group

Tel. Direct +44 (0)20 7549 0994 / +44 (0)7761 974 589

[email protected]

 

Ian Power, Investor Relations

Exova Group plc

Telephone: +44 (0) 131 476 7619[email protected]

 

 

 

Analyst briefing and conference call

 

There will be an analyst briefing and conference call today at 9.30am GMT, held at Investec Bank PLC, Room 701, 7th Floor, 2 Gresham Street, London EC2V 7QP. If you would like to attend the meeting, please contact Powerscourt Group at the above mentioned e-mail address. A copy of the presentation is available on the website.

 

 

Corporate website: www.exova.com

 

 

 

Exova

 

Exova is one of the world's leading laboratory-based testing groups, trusted by organisations to test and advise on the safety, quality and performance of their products and operations. Headquartered in Edinburgh, UK, Exova operates 145 laboratories and offices in 32 countries and employs around 4,500 people throughout Europe, the Americas, the Middle East and Asia/Asia Pacific.

 

Exova's capabilities help to extend asset life, bring predictability to applications, and shorten the time to market for customers' products, processes and materials. With over 90 years' experience, Exova specialises in testing across a number of key sectors from health sciences to aerospace, transportation, oil and gas and construction.

 

 

 

FULL YEAR REPORT 2015

BUSINESS REVIEW

The principal activities of the Group are specialist testing and advisory services and the key markets served are Aerospace; Oil & Gas and Industrials; Product and Certification; Health Sciences and Middle East.

Exova operates primarily in the Testing segment of the Testing, Inspection and Certification ("TIC") sector. It has a growing Certification business, as well as providing Inspection services in a number of niche markets and geographies.

The business comprises 145 permanent facilities in 32 countries and employs around 4,500 people.

Overview of performance

 

 

 

2015

£m

 

 

2014£m 

Growth at reported exchange rates

 

Organic growth

 at constant exchange rates

Revenue

296.5

 

274.9

7.9%

2.3%

Adjusted EBITA1

46.7

 

46.2

1.1%

 

EBITA margin

15.8%

 

16.8%

 

 

 

 

 

 

 

 

Net finance costs

(6.3)

 

(43.3)

 

 

Income tax expense

(4.7)

 

(5.0)

 

 

 

 

 

 

 

 

Earnings per share

6.8p

 

(16.6)p

 

 

Pro-forma adjusted earnings per share

12.2p

 

11.9p2

 

 

 

 

 

 

 

 

Dividend per share

2.2p

 

2.0p

 

 

Cash conversion3

59%

 

68%

 

 

Notes:

 

 

 

 

 

1) Adjusted items are stated before separately disclosed items, 2014 management fee to private equity investors, interest and taxation

2) 2014 pro-forma adjusted earnings per share have been calculated as if the post IPO capital and debt structure had been in place throughout that year.

3) The cash conversion ratio is calculated by dividing free cash flow by adjusted EBITDA. Free cash flow is defined as adjusted EBITDA less movement in net working capital (excluding the effect of the IPO related cost accrual), less capital expenditure net of disposals.

Revenue

 

 

 

 

2015

£m

 

Growth

 

2014 reported

 

Constant currency

 

 

 

274.9

 

Organic

 

 

6.3

2.3%

Acquisitions

 

 

22.5

8.2%

Disposals

 

 

(1.6)

(0.6%)

Growth at constant currency

 

 

302.1

9.9%

Currency effect

 

 

(5.6)

(2.0%)

 

2015 reported

 

 

 

296.5

 

7.9%

 

Revenue for the year was £296.5m which represented organic growth at constant currency of 2.3%.

Acquisitions contributed 8.2% of growth, partly offset by two small disposals which resulted in a reduction of 0.6%. The Group reports in sterling which strengthened during the course of the year over the currencies in most of the territories in which the Group operates. This resulted in a negative translational effect of 2.0%.

Adjusted EBITA margin

Adjusted EBITA margin decreased by 100bps from 16.8% to 15.8%. This reflects the reduction in Oil & Gas and Industrials, plus business investments (including acquisitions) which negatively affected margins.

Separately disclosed items

 

2015

£m

 

2014

£m

Amortisation of intangible assets

8.9

 

9.3

Restructuring costs

4.9

 

2.2

Acquisition and integration costs

3.4

 

1.6

IPO related costs

-

 

13.3

Total

17.2

 

26.4

 

Amortisation of intangible assets

Amortisation of intangible assets for 2015 was £8.9m, a decrease of £0.4m from £9.3m in 2014. This decrease was due to customer relationships acquired from Bodycote now fully amortised partly offset by customer relationship amortisation relating to acquisitions made over the last three years.

Restructuring costs

We incurred £4.9m of restructuring costs in 2015, compared to £2.2 m in 2014. This represents mainly staff redundancy costs relating to rationalisation and restructuring of certain laboratories and administrative departments.

Restructuring costs in 2014 mainly related to closure or disposal of three Oil & Gas and Industrials sites in Norway, Sweden and Canada and other restructuring in this sector.

Acquisition and integration costs

With eight acquisitions completed in 2015 compared to three in 2014, these costs primarily related to the acquisition and integration of BM TRADA Group Limited, Environmental Evaluation Limited, Western Technical Services Limited and on-going expenses to support the pipeline, some of which are expected to close in 2016.

IPO related costs

No IPO related costs were incurred in 2015. In 2014 £13.3m of costs relating to the IPO were incurred. These costs primarily related to commissions, legal, accounting and other adviser fees including irrecoverable VAT in connection with the IPO.

 

Net finance costs

 

 

2015

 

2014

 

£m

 

£m

 

Net cash interest payable

 

 

Bank loans and senior loan notes

5.0

10.1

Other loans and charges

0.1

0.7

Make whole on senior loan notes

-

15.5

Interest income on short-term deposits

-

(0.3)

 

5.1

26.0

Non-cash costs

 

 

Amortisation of debt issue costs

0.7

0.5

Pension interest

0.4

0.1

Unwind of discount on leasehold dilapidations

0.1

0.1

Loan due to parent undertaking

-

8.1

Write-off of historical debt issue costs

-

7.5

Preference share dividend

-

1.0

 

1.2

17.3

Net finance costs

6.3

43.3

 

Net cash interest payable in the year decreased from £26.0m to £5.1m primarily as a result of the refinancing associated with the IPO in April 2014. The increase in pension interest in the current year relates to the retirement benefit obligation assumed with the BM TRADA Group Limited acquisition.

 

Earnings per share ("EPS")

 

Basic earnings per share for the twelve months ended 31 December 2015 was 6.8p (2014: (16.6) p).

Pro-forma adjusted earnings per share for the twelve months ended 31 December 2015 was 12.2p (2014: 11.9p). This measure calculates EPS before separately disclosed items and in 2014 was calculated as if the post IPO capital and debt structure had been in place throughout that year.

 

Dividend

In line with guidance given at the time of the IPO, the Board is recommending a final dividend of 2.2p per share (2014: 2.0p per share) which, together with the interim dividend of 1.0p per share represents a pay-out ratio of 26% of adjusted net income. This reflects the long-term confidence in the business. The dividend will be paid on 10 June 2016 to shareholders on the register at the close of business on 27 May 2016.

Acquisitions

During 2015 the Group completed eight acquisitions.

On 9 February 2015, the Group acquired 100% of the share capital of Environmental Evaluation Limited (EEL) for a consideration of £5.4m. The company helps UK customers meet environmental regulations through the provision of asbestos testing and inspection, stack sampling and occupational hygiene advisory services and is recognised as a leading provider of asbestos management services for the nuclear decommissioning industry. The acquisition added 83 colleagues and forms part of the Group's Health Sciences cluster.

On 13 May 2015, the Group acquired 100% of the share capital of BM TRADA Group Limited ("BM TRADA"). The purchase consideration was £11.1m (net of cash acquired) plus the assumption of a retirement benefit obligation of £11.4m (net of deferred tax). BM TRADA adds to the Group's existing Fire and Building Products testing and certification services and provides a new platform for growth in the attractive area of management systems certification. BM TRADA employs 340 people across 16 countries with annual turnover in excess of £20.0m and has become part of our Product and Certification cluster.

On 2 December 2015, the Group acquired 100% of the share capital of Western Technical Services Limited and Accusense Systems Limited, a specialist provider of non-destructive testing and inspection of components and equipment in the food, dairy, brewing and pharmaceutical industries, for a purchase consideration of £1.7m. This acquisition will form part of the Aerospace cluster.

On 31 December 2015, the Group acquired the environmental monitoring division of Resource and Environmental Consultants Limited for a purchase consideration of £0.1m. This business will be incorporated into our Health Sciences cluster.

Exova Metech, our calibration and metrology business also completed four small acquisitions, two in Sweden and two in Germany. This included the outsourcing of the in-house calibration operation of Sartorius-Werkzeuge and the acquisition of the Eisenhuth calibration businesses which increased our footprint in Germany, part of our planned expansion into northern Europe.

 

On 15 February 2016, the Group acquired a majority stake in Admaterials Technologies Pte Ltd (Admaterials), a Singapore based business that provides testing in the construction sector, as well as chemical, environmental and mechanical testing and certification services. Founded in 2008, Admaterials is one of the leading construction testing businesses in Singapore, as well as providing chemical, environmental and mechanical testing to a range of customers in the private and government sectors. The business has annual revenues in the region of £3.5m, a team of more than 70 specialists and will form part of our Oil & Gas and Industrials cluster.

 

External net debt (excluding debt issue costs)

 

 

 

 

2015

£m

 

2014

£m

 

Term loans

169.7

 

173.5

 

Revolving credit facility

12.0

 

-

 

Finance leases

0.4

0.5

Gross debt

182.1

 

174.0

 

Cash and cash equivalents

(29.1)

 

(29.9)

 

Net debt

153.0

144.1

 

Net debt has increased from £144.1m at 31 December 2014 to £153.0m at 31 December 2015 mainly as a result of the acquisitions made in the year.

At 31 December 2015, our term loans comprised £169.7m of non-amortising borrowings denominated in sterling, euro, Canadian dollars, US dollars and Swedish krona. The amounts drawn down on the revolving credit facility are denominated in sterling. In addition, a £78.0m revolving credit facility was undrawn at 31 December 2015. There are no repayments scheduled on our term loans until 2019.

The net debt to last twelve months Adjusted EBITDA ratio was 2.6x as at 31 December 2015 (2014: 2.5x). Based on the definition in the bank covenant, net debt to Adjusted EBITDA ratio is 2.4x (2014: 2.4x).

Presentation of results

Constant currency growth figures are provided in order to remove the impact of currency translation. We calculate growth at constant rates by translating the current and prior period revenue at the same exchange rates.

Organic growth at constant currency represents revenue growth at constant currency excluding the growth attributable to acquisitions until the acquisition has been owned for a 12 month period and excluding the revenue attributable to disposals in the year of disposal and the preceding year.

Adjusted results are stated before separately disclosed items, 2014 management fee to private equity investor, interest and taxation.

The Group presents, as separately disclosed items on the face of the income statement, those items of income and expense which, because of their nature, merit separate presentation to allow users to understand better the elements of financial performance in the period to facilitate a comparison with prior periods and a better assessment of trends in financial performance.

Foreign exchange

 

Exchange rates for the most significant currencies used by the Group during the year were:

 

 

 

 

Average rate

2015

Closing rate

2015

Average rate

2014

Closing rate

2014

Euro

 

 

1.378

1.357

1.241

1.278

US dollar

 

 

1.532

1.483

1.652

1.553

Canadian dollar

 

 

1.957

2.056

1.823

1.807

Swedish krona

 

 

12.913

12.446

11.289

12.130

UAE dirham

 

 

5.630

5.447

6.068

5.707

Qatari riyal

 

 

5.585

5.404

6.019

5.662

 

 

 

OPERATING PERFORMANCE

 

Revenue

 

 

 

 

2015

£m

 

 

2014£m 

Growth at reported exchange rates

Organic growth

 at constant exchange rates

 

Europe

156.9

 

142.7

10.0%

1.2%

 

Americas

99.5

 

97.5

2.1%

2.0%

 

Rest of World

40.1

 

34.7

15.6%

7.2%

 

Group

296.5

 

274.9

7.9%

2.3%

 

 

 

 

 

2015

£m

 

 

2014£m 

Growth at reported exchange rates

Organic growth

 at constant exchange rates

Aerospace

46.0

 

44.9

2.4%

4.6%

Oil & Gas and Industrials

69.1

 

80.3

(13.9)%

(11.2)%

Product and Certification

95.2

 

74.2

28.3%

10.0%

Health Sciences

57.5

 

51.3

12.1%

5.8%

Middle East

28.7

 

24.2

18.6%

10.4%

Group

296.5

 

274.9

7.9%

2.3%

 

Adjusted EBITA

 

2015

£m

 

Margin

 

2014

£m

 

Margin

 

Europe

21.1

13.5%

20.8

14.6%

Americas

20.7

20.8%

21.1

21.6%

Rest of World

4.9

12.3%

4.3

12.4%

Group

46.7

15.8%

46.2

16.8%

 

 

Regional Performance

Europe

 

 

2015

£m

 

 

2014£m 

Growth at reported exchange rates

 

Organic growth

at constant exchange rates

 

Revenue

156.9

 

142.7

10.0%

1.2%

Adjusted EBITA

21.1

 

20.8

1.4%

 

Margin

13.5%

 

14.6%

(110)bps

 

 

Aerospace

Following a flat 2014, the European aerospace sector returned to good organic growth in 2015. Growth was driven by strong performances with the supply chains of OEMs supporting increased build rates. There has been a shift in mix for the sector towards production release testing. New material developments have helped to maintain research and development volumes despite no completely new airframe platforms being developed in Europe.

In the UK, continued investment in the latest technology enabled the sector to continue to support the development programmes of the European aerospace OEMs, work that looks set to grow further in 2016. The benefits of strong cost control and service delivery contributed to a strong performance from our Non Destructive Testing (NDT) business.

Oil & Gas and Industrials

The impact of low oil prices led to contraction and price pressure in the oil & gas testing market. Despite a relatively strong start to the year as a result of the completion of some 2014 projects, we experienced lower levels of new approved projects later in the year.

During the year cost action was taken to mitigate volume and price pressures in line with the market and we will continue to monitor our cost base closely. Additionally, and as part of the focus on diversification, we won a number of contracts with non-oil & gas customers. In our Industrials sector, the Swedish polymers business experienced a strong order book, driven by a particularly good year for chlorine testing.

Product and Certification

Fire, Building Products and Certification had another successful year across all European locations. Regulations and standards helped support the positive testing and certification pipeline. The acquisition of BM TRADA increased fire testing capacity as well as extending the overall scope of building products testing and certification. It also saw Exova enter into Management Systems and Chain of Custody certification for the first time.

Our calibration business continued to perform very well. We completed four small acquisitions - Eisenhuth, QA Viking, a calibration laboratory in Kista, Stockholm and the outsourcing of the in-house calibration operation of Sartorius-Werkzeuge, which together added around £1m of revenue on an annualised basis. As a result we have been able to extend our service range, consolidate our market position in Sweden and improve our foothold in the German market.

Health Sciences

Last year's strong organic growth continued in 2015 with further major contract wins in the food business. This was through a continued focus on food safety and integrity by both retail and manufacturing clients as well as the commissioning of new manufacturing operations and associated testing by a number of our larger clients. Our water testing business in the UK continued to perform well and, as a result, additional capacity was introduced through the opening of a new laboratory in the south of England in December. There was also continued growth in our pharmaceutical business as a result of new contract wins.

Our environmental testing business continued to flourish with the Catalyst stack emissions testing operation delivering strong double-digit growth. As part of the region's strategy to expand and develop its capability in environmental testing, this was further enhanced through the acquisition in February of Environmental Evaluation Limited (EEL). The stack emissions operations of EEL were integrated into the Catalyst business, providing increased capacity for growth across the UK. EEL's asbestos surveying operation complemented our existing business in Scotland, creating a UK-wide network for this capability.

 

Americas

 

 

 

 

2015

£m

 

 

2014£m 

Growth at reported exchange rates

 

Organic growth

 at constant exchange rates

 

Revenue

99.5

 

97.5

2.1%

2.0%

Adjusted EBITA

20.7

 

21.1

(1.9%)

 

Margin

20.8%

 

21.6%

(80)bps

 

 

Aerospace

Our Aerospace business continued to focus primarily on the commercial aviation market, in addition to the defence and space industries. We saw strong performance in 2015, driven by growth and expansion in our laboratories in southern California and Mexico. We continued to make investments in upgrading our capabilities and capacity, and expanded our scope of accreditations in many locations to better serve the needs of our customers. We are now well positioned to capitalise on our investments in high-growth areas such as fatigue testing and ceramic matrix composite (CMC) testing, while continuing to support testing innovations in new technically demanding service areas like additive manufacturing. With a substantial backlog in airframe orders, we expect continued growth in our Aerospace testing business.

Oil & Gas and Industrials

With the significant reduction in the oil price, the Gulf of Mexico oil and gas market experienced a slowdown in new project work. Additionally, the primary and secondary steel sectors have been significantly impacted by price pressures and cheaper imports affecting the regional markets, leading to an overall contraction in the cluster. This was somewhat mitigated by better performance in the general industrials market, both in the US and Canada. In October we opened a new laboratory in Pittsburgh, Pennsylvania our first facility in the north east of the USA, specialising in materials and corrosion testing, supplemented by failure analysis and risk assessment advisory services.

A combination of large projects, spill events, more regulatory work and growth with certain oil and gas clients helped our Western Canada business perform well in a difficult market.

Product and Certification

Revenue from our Transportation sector increased in 2015 due to the continued strength of the US Automotive market. With an increase in vehicle launches, both the Warren and Troy laboratories in Michigan experienced growth. In Warren, growth was driven by automotive interiors testing, with major programmes completed for several Tier One Automotive customers. In addition, a major project for durability of automotive axles in Warren contributed to a strong finish to 2015. The Troy laboratory benefited from several major structural durability projects for US Automotive OEMs and Tier One suppliers.

Revenue from our engine-testing programmes increased significantly due to high volumes of on-site testing work and a two-year programme extension for another test site was won.

Health Sciences

Health Sciences contracted due to a weak performance in the environment business that was impacted by severe weather conditions in the first half, which resulted in a very late start to the season and a very competitive market environment.

Several long-term agreements and continued strong demand for specialised testing and development capabilities contributed to growth in the Canadian and US pharmaceutical businesses, reaping benefits from capital investments made to support these activities. Investment in IT systems continues to help us provide an improved customer service experience. Our food laboratory in Portland, Oregon had a solid year with the addition of a new key account, broadening the client base in a tight market.

 

Rest of World

 

 

 

 

2015

£m

 

 

2014£m 

Growth at reported exchange rates

 

Organic growth

 at constant exchange rates

 

Revenue

40.1

 

34.7

15.6%

7.2%

Adjusted EBITA

4.9

 

4.3

14.0%

 

Margin

12.3%

 

12.4%

(10)bps

 

 

Middle East

The market continued to grow strongly in the Middle East, driven by continued major infrastructure spending in Saudi Arabia, Qatar and Oman. Good revenues flowed from two Metro projects and infrastructure programmes such as the 2022 World Cup in Qatar.

UAE/Oman: Government-funded projects in Oman delivered increased demand for materials testing services and we also saw significant growth in chemistry services in the UAE and Oman, generated by a large water storage project and mineral characterisation work respectively. While materials testing in Dubai grew, there was a lower level of environmental-related project work, leading to an overall contraction. The Abu Dhabi market remained relatively flat.

Saudi Arabia/Qatar: Revenues from materials testing on civil engineering projects in Saudi Arabia and Qatar increased significantly year on year due to the award of new infrastructure projects, such as the Metro projects in Riyadh and Doha, on which we expect to have significant participation in the years ahead.

Oil & Gas and Industrials

We were able to grow our overall sales in the region through the provision of our innovative, high-specification "laboratory in a box" for Subsea 7 in support of its project work in offshore Angola. Through increased investment in coatings testing, we have ensured Exova Singapore is a 'one-stop-shop' for coatings tests related to the oil & gas and marine coatings market.

Our Indian business, acquired in 2014, has been successfully integrated into the region and recently completed the development of a new state-of-the-art laboratory that will allow us to perform better sour service-related corrosion testing. We experienced headwinds in the oil & gas market and while these were less severe than in other regions, we took the necessary cost actions in the second half to mitigate their impact.

Product and Certification

In the Middle East, in our Fire business we saw a general reduction in the overall number of large projects being tendered. Australia Fire Consulting successfully extended its scope by adding fire façade testing to its portfolio.

Outlook

The Board currently expects to deliver modest organic growth at constant currency in 2016. This demonstrates the strength of our portfolio and model. With deals completed in 2015 and a strong pipeline going into 2016, we expect our M&A programme to continue to contribute significantly to overall growth. As a result of management actions taken in 2015 and the continued focus on our cost base, we expect 2016 group margins to be broadly similar to the prior year.

Our medium term revenue expectation remains mid-single digit organic growth and additional continued expansion through acquisitions with gradual margin improvement.

 

GROUP INCOME STATEMENT

For the year ended 31 December 2015

 

 

 

 

Before separately disclosed items

Separately disclosed items

(note 3)

2015

Total

 

 

Before separately disclosed items

Separately disclosed items

 

2014

Total

 

 

Continuing operations

 

Notes

£m

£m

£m

 

£m

£m

£m

Revenue

2

296.5

-

296.5

 

274.9

-

274.9

Net operating costs

 

(249.8)

(17.2)

(267.0)

 

(228.9)

(26.4)

(255.3)

Operating profit

 

46.7

(17.2)

29.5

 

46.0

(26.4)

19.6

Finance costs

4

(6.3)

-

(6.3)

 

(43.6)

-

(43.6)

Finance income

4

-

-

-

 

0.3

-

0.3

Profit / (loss) before taxation

 

40.4

(17.2)

23.2

 

2.7

(26.4)

(23.7)

Income tax

 

(8.5)

3.8

(4.7)

 

(8.8)

3.8

(5.0)

Profit / (loss) for the year

 

31.9

(13.4)

18.5

 

(6.1)

(22.6)

(28.7)

 

 

 

 

 

 

Profit / (loss) attributable to:

 

 

 

 

 

Equity holders of the Parent

 

 

17.1

 

 

 

(29.9)

Non-controlling interests

 

 

1.4

 

 

 

1.2

Profit / (loss) for the year

 

 

18.5

 

 

 

(28.7)

 

 

 

 

 

 

Earnings per share *

 

 

 

 

 

Basic

5

 

6.8p

 

 

(16.6)p

Diluted

5

 

6.8p

 

 

(16.6)p

             

 

* Earnings per share on adjusted results are disclosed in Note 5.

 

 

GROUP STATEMENT OF COMPREHENSIVE INCOME

For the year ended 31 December 2015

 

 

 

 

2015

 

2014

 

 

£m

 

£m

Profit / (loss) for the year

 

18.5

 

(28.7)

 

 

 

 

 

Other comprehensive income to be reclassified in profit or loss in subsequent periods

 

 

 

 

Exchange differences on translation of foreign operations and related borrowings

 

(5.2)

 

(2.9)

 

 

 

 

 

Other comprehensive income not to be reclassified to profit or loss in subsequent periods

 

 

 

 

Actuarial gain / (loss) on defined benefit plans

 

1.2

 

(1.5)

Income tax effect

 

(0.4)

 

0.4

Impact of rate change on deferred tax

 

(0.3)

 

-

Other comprehensive income for the year (net of tax)

 

(4.7)

 

(4.0)

 

 

 

 

 

Total comprehensive income for the year

 

13.8

 

(32.7)

 

 

 

 

 

Total comprehensive income for the year attributable to:

 

 

 

 

Equity holders of the Parent

 

12.3

 

(34.0)

Non-controlling interests

 

1.5

 

1.3

Total comprehensive income for the year

 

13.8

 

(32.7)

 

 

GROUP BALANCE SHEET

As at 31 December 2015

 

 

 

 

 

Notes

 

2015

 

 

£m

 

2014

Restated

Note 1

£m

 

Assets

 

 

 

 

Non-current assets

 

 

 

 

Goodwill

 

 

355.1

335.4

Intangible assets

 

 

17.7

14.4

Property, plant and equipment

7

 

68.7

64.7

Government grants

 

 

7.1

8.8

Deferred tax assets

 

 

8.0

6.9

Investments in joint ventures

 

 

 

0.2

-

 

 

 

456.8

430.2

Current assets

 

 

 

 

Trade and other receivables

 

 

74.5

65.1

Income tax receivable

 

 

0.3

1.2

Cash and short-term deposits

 

 

29.2

29.9

 

 

 

104.0

96.2

Total assets

 

 

560.8

526.4

 

 

 

 

 

Equity

 

 

 

 

Issued share capital

 

 

2.5

2.5

Share premium

 

 

109.5

109.5

Merger reserve

 

 

324.5

324.5

Capital contribution reserve

 

 

114.9

114.9

Foreign currency translation reserve

 

 

(5.4)

(0.1)

Retained earnings

 

 

 

(262.9)

 

(273.4)

 

Equity attributable to equity holders of the Parent

 

 

283.1

277.9

Non-controlling interests

 

 

 

4.7

3.7

Total equity

 

 

287.8

281.6

 

Liabilities

 

 

 

 

Non-current liabilities

 

 

 

 

Bank and other borrowings

9

 

167.6

170.8

Finance leases

9

 

0.3

0.3

Retirement benefit obligations

 

 

15.8

3.1

Provisions

 

 

6.7

7.2

Deferred tax liabilities

 

 

10.4

10.4

Other liabilities

 

 

6.4

5.0

 

 

 

207.2

196.8

 

Current liabilities

 

 

 

 

Bank and other borrowings

9

 

12.1

-

Finance leases

9

 

0.1

0.2

Trade and other payables

 

 

50.5

44.5

Provisions

 

 

3.1

3.3

 

 

 

 

65.8

48.0

Total liabilities

 

 

273.0

244.8

Total equity and liabilities

 

 

560.8

526.4

 

GROUP STATEMENT OF CHANGES IN EQUITY

For the year ended 31 December 2015

 

 

 

 

Attributable to equity holders of the Parent

 

 

 

 

Share capital

Share premium

Merger reserve

Capital contribution reserve

Foreign currency translation reserve

Retained earnings

Total shareholders' equity

Non-controlling interests

Total equity

 

Notes

£m

£m

£m

£m

£m

£m

£m

£m

£m

At 1 January 2014

 

4.4

-

-

114.9

2.9

(244.1)

(121.9)

2.9

(119.0)

(Loss)/profit for the year

 

-

-

-

-

-

(29.9)

(29.9)

1.2

(28.7)

Other comprehensive

income

 

 

-

-

-

-

(3.0)

(1.1)

(4.1)

0.1

(4.0)

Total comprehensive

income for the year

 

-

-

-

-

(3.0)

(31.0)

(34.0)

1.3

(32.7)

Share-based payments

 

-

-

-

-

-

1.4

1.4

-

1.4

Capitalisation of

shareholder loan

 

0.7

-

277.5

-

-

-

278.2

-

278.2

Conversion of preference

share capital

 

34.2

-

9.9

-

-

-

44.1

-

44.1

Redemption of deferred

share capital

 

(37.3)

-

37.1

-

-

0.3

0.1

-

0.1

Issue of share capital

 

0.5

109.5

-

-

-

-

110.0

-

110.0

Dividends to non-

controlling interests

 

 

-

-

-

-

-

-

-

(0.5)

(0.5)

At 31 December 2014

 

 

2.5

109.5

324.5

114.9

(0.1)

(273.4)

277.9

3.7

281.6

 

 

 

 

 

 

 

 

 

 

 

At 1 January 2015

 

 

2.5

109.5

324.5

114.9

(0.1)

(273.4)

277.9

3.7

281.6

Profit for the year

 

-

-

-

-

-

17.1

17.1

1.4

18.5

Other comprehensive

income

 

 

-

-

-

-

(5.3)

0.5

(4.8)

0.1

(4.7)

Total comprehensive

income for the year

 

-

-

-

-

(5.3)

17.6

12.3

1.5

13.8

Share-based payments

 

-

-

-

-

-

0.4

0.4

-

0.4

Dividends

 

6

 

-

 

-

 

-

 

-

 

-

 

(7.5)

 

(7.5)

 

(0.5)

 

(8.0)

 

At 31 December 2015

 

 

2.5

109.5

324.5

114.9

(5.4)

(262.9)

283.1

4.7

287.8

            
 

GROUP STATEMENT OF CASH FLOWS

For the year ended 31 December 2015

 

 

 

 

2015

 

2014

 

Notes

£m

£m

 

£m

£m

Profit / (loss) before taxation

 

 

23.2

 

 

(23.7)

Depreciation of property, plant and equipment

 

 

12.4

 

 

11.2

Amortisation of intangible assets

 

 

8.9

 

 

9.3

Gain on sale of property, plant and equipment

 

 

-

 

 

(1.6)

Government grants

 

 

(0.6)

 

 

(1.0)

Share-based payments

 

 

0.4

 

 

1.4

Non-cash movement in defined benefit pension obligations

 

 

0.5

 

 

0.2

Net finance costs

4

 

6.3

 

 

43.3

Operating cash flows before movements in working capital

 

 

 

51.1

 

 

 

39.1

 

 

 

 

 

 

 

 

Increase in trade and other receivables

 

(3.8)

 

 

(4.5)

 

Decrease in provisions and retirement benefit obligations

 

(1.7)

 

 

(0.8)

 

(Decrease) / increase in trade and other payables

 

(2.0)

 

 

0.3

 

Movements in working capital

 

 

 

(7.5)

 

 

 

(5.0)

 

 

 

 

 

 

 

 

Cash generated from operations

 

 

43.6

 

 

34.1

 

 

 

 

 

 

 

Interest paid

 

 

(5.1)

 

 

(29.5)

Tax paid

 

 

(3.7)

 

 

(7.3)

Net cash flows from / (used in) operating activities

 

 

34.8

 

 

(2.7)

 

 

 

 

 

 

 

Investing activities

 

 

 

 

 

 

Purchase of property, plant and equipment

 

 

(15.7)

 

(16.3)

 

Purchase of intangible assets

 

 

(1.8)

 

(0.9)

 

Acquisition of subsidiary undertakings (net of cash acquired)

8

 

(21.8)

 

(11.4)

 

Proceeds from sale of property, plant and equipment

 

 

0.2

 

2.4

 

Interest received

 

 

-

 

0.3

 

Net cash flows used in investing activities

 

 

 

(39.1)

 

 

 

(25.9)

 

 

 

 

 

 

 

 

Net cash flows before financing activities

 

 

(4.3)

 

 

(28.6)

 

 

 

 

 

 

 

Financing activities

 

 

 

 

 

 

Proceeds from borrowings

 

 

17.0

 

170.0

 

Repayment of bank borrowings

 

 

(5.0)

 

(94.2)

 

Payment of finance lease liabilities

 

 

(0.2)

 

(0.1)

 

Dividends paid to shareholders

6

 

(7.5)

 

-

 

Dividends paid to non-controlling interests

 

 

(0.5)

 

(0.5)

 

Senior loan notes redemption

 

 

-

 

(155.0)

 

Repayment of other borrowings

 

 

-

 

(0.3)

 

Repayment of loans to minority shareholders

 

 

-

 

(0.3)

 

IPO proceeds

 

 

-

 

110.0

 

Debt issue costs paid

 

 

-

 

(3.4)

 

Net cash flows from financing activities

 

3.8

 

 

26.2

Net decrease in cash and cash equivalents

 

 

(0.5)

 

 

(2.4)

Cash and cash equivalents at 1 January

 

 

29.9

 

 

32.0

Effects of exchange rate changes

 

 

(0.3)

 

 

0.3

Cash and cash equivalents at 31 December

 

 

29.1

 

 

29.9

 

 

 

 

 

 

 

Separately disclosed items included in cash flow from/(used in) operating activities

(8.3)

 

 

(19.8)

 

 

NOTES TO THE FULL YEAR RESULTS ANNOUNCEMENT

For the year ended 31 December 2015

 

 

1. BASIS OF PREPARATION AND CHANGES TO THE GROUP'S ACCOUNTING POLICIES

 

The audited results for the year ended 31 December 2015 ("2015") have been prepared in accordance with International Financial Reporting Standards (IFRS) as adopted by the European Union and applied in accordance with the provisions of the Companies Act 2006.

The financial information set out in the audited results does not constitute the Group's statutory financial statements for the year ended 31 December 2015 within the meaning of Section 434 of the Companies Act 2006 and has been extracted from the full financial statements for the year ended 31 December 2015.

 

Statutory financial statements for the year ended 31 December 2014, which received an unqualified audit report, have been delivered to the Registrar of Companies. The reports of the auditors on the financial statements for the year ended 31 December 2014 and for the year ended 31 December 2015 were unqualified and did not contain a statement under either Section 498(2) or Section 498(3) of the Companies Act 2006. The financial statements for the year ended 31 December 2015 will be delivered to the Registrar of Companies and made available to all shareholders in due course.

 

Basis of consolidation

 

The consolidated financial statements comprise the financial statements of the Group and its subsidiaries as at 31 December 2015. Control is achieved when the Group is exposed, or has rights, to variable returns from its involvement with the investee and has the ability to affect those returns through its power over the investee. Specifically, the Group controls an investee if, and only if, the Group has:

 

- power over the investee (i.e. existing rights that give it the current ability to direct the relevant activities of the investee);

- exposure, or rights, to variable returns from its involvement with the investee; and

- the ability to use its power over the investee to affect its returns.

 

Generally, there is a presumption that a majority of voting rights result in control. To support this presumption and when the Group has less than a majority of the voting or similar rights of an investee, the Group considers all relevant facts and circumstances in assessing whether it has power over an investee, including:

 

- the contractual arrangement with the other vote holders of the investee;

- rights arising from other contractual arrangements; and

- the Group's voting rights and potential voting rights.

 

The Group re-assesses whether or not it controls an investee if facts and circumstances indicate that there are changes to one or more of the three elements of control. Consolidation of a subsidiary begins when the Group obtains control over the subsidiary and ceases when the Group loses control of the subsidiary. Assets, liabilities, income and expenses of a subsidiary acquired or disposed of during the year are included in the consolidated financial statements from the date the Group gains control until the date the Group ceases to control the subsidiary.

 

Restatement

 

During the year, the provisional fair values attributable to the 2014 acquisitions of Raufoss Offshore Limited and Metallurgical Services Private Limited were finalised. In the balance sheet the effect has been to increase goodwill by £0.6m and to reduce intangible assets and deferred tax liabilities by £0.9m and £0.3m respectively. Note 8 "Business combinations" provides further details.

 

New standards, interpretations and amendments adopted by the Group

 

The accounting policies adopted in the preparation of the consolidated financial statements are consistent with those followed in the preparation of the Group's annual consolidated financial statements for the year ended 31 December 2014, except for the adoption of a new accounting policy on joint ventures as noted below.

The Group has not early adopted any other standard, interpretation or amendment that has been issued but not yet effective. There are no standards or interpretations effective for the first time in the financial period with a significant impact on the Group's consolidated results or financial position.

 

As a result of the acquisition of BM TRADA Group Limited, and the joint venture companies within that group, the Group has adopted the following accounting policy during the year:

Joint ventures

 

A joint venture is a type of joint arrangement whereby the parties that have joint control of the arrangement have rights to the net assets of the joint venture. Joint control is the contractually agreed sharing of control of an arrangement, which exists only when decisions about the relevant activities require unanimous consent of the parties sharing control. The Group's investments in joint ventures are accounted for using the equity method.

Under the equity method, the investment in a joint venture is initially recognised at cost. The carrying amount of the investment is adjusted to recognise changes in the Group's share of net assets of the joint venture since the acquisition date. Goodwill relating to the joint venture is included in the carrying amount of the investment and is not tested for impairment individually. The income statement reflects the Group's share of the results of operations of the joint venture. Any change in other comprehensive income of those investees is presented as part of the Group's other comprehensive income. In addition, when there has been a change recognised directly in the equity of the joint venture, the Group recognises its share of any changes, when applicable, in the statement of changes in equity. Unrealised gains and losses resulting from transactions between the Group and the joint venture are eliminated to the extent of the interest in the joint venture. The aggregate of the Group's share of profit or loss of a joint venture is shown on the face of the income statement.

 

2. SEGMENTAL REPORTING

For management purposes, the Group is organised into three operating regions: Europe, Americas and Rest of World. These three regions are organised and managed separately based on the geographies served and each is treated as an operating segment and a reportable segment in accordance with IFRS 8 Operating Segments. The operating and reportable segments were determined based on reports reviewed by the Directors which are used to make operational decisions.

 

 

Management monitors the operating results of its business units separately for the purpose of making decisions about resource allocation and performance assessment. Segment performance is evaluated based on Adjusted EBITA and is measured consistently in the consolidated financial statements. However, group financing (including finance costs and finance income), IPO related costs and income taxes are managed centrally and are not allocated to operating segments.

 

 

Transfer prices between operating segments are on an arm's length basis in a manner similar to transactions with third parties and inter-segment revenues are eliminated on consolidation.

 

 

2015

Europe

Americas

Rest of World

Eliminations

Unallocated

Total

 

 

£m

£m

£m

£m

£m

£m

 

Operations

 

 

 

 

 

 

 

Revenue - external customers

156.9

99.5

40.1

-

-

296.5

 

Revenue - inter-business segments

0.5

1.2

1.5

(3.2)

-

-

 

Total revenue

157.4

100.7

41.6

(3.2)

-

296.5

 

 

 

 

 

 

 

 

 

Adjusted EBITDA

27.2

25.3

6.6

-

-

59.1

 

Depreciation

(6.1)

(4.6)

(1.7)

-

-

(12.4)

 

Adjusted EBITA

21.1

20.7

4.9

-

-

46.7

 

Amortisation of intangible assets

(4.9)

(2.3)

(1.7)

-

-

(8.9)

 

Acquisition and integration costs

(2.9)

(0.1)

(0.4)

-

-

(3.4)

 

Restructuring costs

(3.1)

(1.6)

(0.2)

-

-

(4.9)

 

Segmental operating profit

10.2

16.7

2.6

-

-

29.5

 

Net finance costs

-

-

-

-

(6.3)

(6.3)

 

Profit / (loss) before tax

10.2

16.7

2.6

-

(6.3)

23.2

 

Income tax

-

-

-

-

(4.7)

(4.7)

 

Profit / (loss) for the year

10.2

16.7

2.6

-

(11.0)

18.5

 

 

 

 

2014

Europe

Americas

Rest of World

Eliminations

Unallocated

Total

 

 

£m

£m

£m

£m

£m

£m

 

Operations

 

 

 

 

 

 

 

Revenue - external customers

142.7

97.5

34.7

-

-

274.9

 

Revenue - inter-business segments

0.3

0.6

1.0

(1.9)

-

-

 

Total revenue

143.0

98.1

35.7

(1.9)

-

274.9

 

 

 

 

 

 

 

 

 

Adjusted EBITDA

26.4

25.2

5.8

-

-

57.4

 

Depreciation

(5.6)

(4.1)

(1.5)

-

-

(11.2)

 

Adjusted EBITA

20.8

21.1

4.3

-

-

46.2

 

Management fee to private equity investor

(0.1)

(0.1)

-

-

-

(0.2)

 

Operating profit before separately disclosed items

20.7

21.0

4.3

-

-

46.0

 

Amortisation of intangible assets

(4.7)

(2.6)

(2.0)

-

-

(9.3)

 

Acquisition and integration costs

(0.4)

(0.5)

(0.7)

-

-

(1.6)

 

Restructuring costs

(0.4)

(1.6)

(0.2)

-

-

(2.2)

 

IPO related costs

-

-

-

-

(13.3)

(13.3)

 

Segmental operating profit

15.2

16.3

1.4

-

(13.3)

19.6

 

Net finance costs

-

-

-

-

(43.3)

(43.3)

 

Profit / (loss) before tax

15.2

16.3

1.4

-

(56.6)

(23.7)

 

Income tax

-

-

-

-

(5.0)

(5.0)

 

Profit / (loss) for the year

15.2

16.3

1.4

-

(61.6)

(28.7)

 

            

3. SEPARATELY DISCLOSED ITEMS 

 

2015

£m

2014

£m

Amortisation of intangible assets

8.9

9.3

Restructuring costs

4.9

2.2

Acquisition and integration costs

3.4

1.6

IPO related costs

-

13.3

 

17.2

26.4

 

 

 

Income tax credit

(3.8)

(3.8)

 

13.4

22.6

The Group presents, as separately disclosed items on the face of the Group income statement, those items of income and expense which, because of their nature, merit separate presentation to allow users to understand better the elements of financial performance in the year to facilitate a comparison with prior years and a better assessment of trends in financial performance.

Included in the income tax credit is £2.0m (2014: £2.3m) related to the amortisation of the deferred tax liability in respect of customer relationships. The remaining income tax credit of £1.8m (2014: £1.5m) relates to restructuring, amortisation and integration costs.

 

 

4. NET FINANCE COSTS

 

 

 

 

2015

2014

 

£m

£m

Finance costs:

 

 

Bank loans and senior loan notes

5.0

10.1

Other loans and charges

0.2

0.8

Amortisation of debt issue costs

0.7

0.5

Pension interest

0.4

0.1

Make whole on senior loan notes

-

15.5

Loan due to parent undertaking

-

8.1

Preference shares dividend

-

1.0

Write-off of historical debt issue costs

-

7.5

Total finance costs

6.3

43.6

Finance income:

 

 

Interest income on short-term deposits

-

(0.3)

Total finance income

-

(0.3)

Net finance costs

6.3

43.3

 

5. EARNINGS PER SHARE

 

Based on the profit for the year:

 

Notes

2015

£m

2014

£m

 

Profit / (loss) attributable to equity holders of the Parent Company

17.1

(29.9)

 

Separately disclosed items

3

13.4

22.6

 

Adjusted earnings after tax

30.5

(7.3)

 

 

 

 

 

Number of shares:

 

2015

m

2014

m

 

Basic weighted average number of ordinary shares

250.4

179.9

 

Potentially dilutive share awards

0.3

-

 

Diluted weighted average number of shares

250.7

179.9

 

 

 

 

 

 

2015

2014

 

 

pence

pence

 

Basic earnings per share

6.8

(16.6)

 

Share awards

-

-

 

Diluted earnings per share

6.8

(16.6)

 

 

 

 

 

Basic adjusted earnings per share

12.2

(4.1)

 

Share awards

-

-

 

Diluted adjusted earnings per share

12.2

(4.1)

 

 

Basic earnings per share (EPS) amounts are calculated by dividing the profit for the year attributable to the ordinary equity holders of the Parent Company by the weighted average number of ordinary shares outstanding during the year.

 

 

In the prior year, the dilutive effect of potential ordinary shares through equity settled transactions were considered to be anti-dilutive as they would have decreased the loss per share from continuing operations and were therefore excluded from the calculation of diluted EPS.

 

      

6. DIVIDENDS 

Dividends on ordinary shares

 

 

 

2015

£m

 

2014

£m

 

 

Interim paid in respect of 2015: 1.0p per share

2.5

-

 

Final paid in respect of 2014: 2.0p per share

 

5.0

-

 

 

7.5

-

 

 

Proposed dividends

 

 

 

The Board is recommending a final dividend of 2.2p per share (2014: 2.0p per share). The dividend will be paid on 10 June 2016 to shareholders on the register at the close of business on 27 May 2016.

 

 

7. PROPERTY, PLANT AND EQUIPMENT

Acquisitions and disposals

During the year ended 31 December 2015, the Group capitalised assets with a cost of £17.5m including £1.8m from business combinations (note 8) (2014: £17.5m including £1.0m from business combinations).

 

Assets with a carrying value of £0.1m were disposed of during the year ended 31 December 2015 (2014: £0.9m).

The negative impact of foreign exchange on the total carrying amount of property, plant and equipment in the year ended 31 December 2015 was £1.0m (2014: £0.2m negative impact).

The net book value of property, plant and equipment was as follows:

 

2015

£m

2014

£m

 

Land and buildings

16.1

 

16.5

Plant and equipment

52.6

48.2

Total property, plant and equipment

68.7

64.7

 

Property, plant and equipment include £0.4m (2014: £0.5m) of assets held under finance leases.

 

Capital commitmentsAt 31 December 2015 the Group had commitments to purchase property, plant and equipment for £3.4m (2014: £2.2m).

 

8. BUSINESS COMBINATIONS

Acquisitions in 2015

 

During the year, the Group acquired the companies below with fair values as set out in the following table:

 

 

 

Environmental Evaluation Limited

BM TRADA Group Limited

Western Technical Services and Accusense Systems Limited

Others

Total

 

£m

£m

£m

£m

£m

Investments in joint ventures

-

0.2

-

-

0.2

Intangible assets

1.7

8.6

0.2

-

10.5

Property, plant and equipment

0.3

1.2

-

0.3

1.8

Deferred tax assets

-

3.0

-

-

3.0

Trade and other receivables

0.7

5.5

0.3

0.1

6.6

Cash and cash equivalents

0.6

3.2

0.3

0.2

4.3

Trade and other payables

(0.7)

(11.2)

(0.2)

(0.1)

(12.2)

Income tax payable

-

(0.2)

(0.2)

-

(0.4)

Long-term provisions

-

-

-

(0.1)

(0.1)

Retirement benefit obligations

-

(14.2)

-

-

(14.2)

Deferred tax liabilities

(0.4)

(1.7)

-

-

(2.1)

Net assets acquired

2.2

(5.6)

0.4

0.4

(2.6)

Goodwill

3.2

19.9

1.3

1.2

25.6

Total purchase price

5.4

14.3

1.7

1.6

23.0

Acquired cash and cash equivalents

(0.6)

(3.2)

(0.3)

(0.2)

(4.3)

Deferred consideration

(0.1)

(0.1)

-

(0.1)

(0.3)

Contingent consideration

-

-

(0.3)

-

(0.3)

Net cash outflow on acquisitions

4.7

11.0

1.1

1.3

18.1

 

Purchase consideration:

 

 

 

 

 

Gross cash consideration paid in the year

5.3

14.2

1.4

1.5

22.4

Deferred consideration

0.1

0.1

-

0.1

0.3

Contingent consideration

-

-

0.3

-

0.3

 

5.4

14.3

1.7

1.6

23.0

 

 

During the year the following payments were made for acquisitions completed during the current and prior year:

 

 

 

2015

£m

Contingent consideration

 

3.5

Purchase price adjustment

 

0.2

Net cash outflow on acquisitions made in the prior year

 

3.7

Net cash outflow on acquisitions in the current year

 

18.1

Total net cash outflow for the year

 

21.8

 

 

At year-end, the initial accounting for the acquisitions made between 1 May 2015 and 31 December 2015 is not complete due to the timing of the transactions. Therefore the fair value amounts disclosed above are provisional and may be subject to further adjustments following the completion of the fair value assessment exercises.

 

 

No material adjustments have been made in respect of the trade and other receivables acquired.

 

Goodwill

The goodwill of £25.6m comprises the fair value of the expected synergies arising from the acquisitions and the value of the human capital that does not meet the criteria for recognition as a separable intangible asset.

 

 

Contribution of acquisitions to revenue and profits

 

From the dates of acquisition the newly acquired subsidiaries contributed £21.2m to revenue and, if the acquisitions were assumed to have been made on 1 January 2015, the Group revenue would have been £307.3m.

 

No profit figures are disclosed as these businesses have now been integrated into the rest of the Group and therefore it would be impracticable to obtain a meaningful profit number.

 

 

Restatement (note 1)

 

In the 2014 financial statements, the fair value of the acquisitions of Raufoss Offshore and Metallurgical Services Private Limited were provisional due to the timing of the transactions. The fair values have now been finalised resulting in adjustments to the provisional fair values attributed. The following table summarises the adjustments made to the provisional values during the year.

 

The fair values are set out in the following table:

 

Provisional fair values

Purchase price adjustment

Adjustment to provisional fair values

Final fair

 values

 

£m

 

£m

£m

£m

 

Intangible assets

2.4

-

(0.9)

1.5

Property, plant and equipment

0.5

-

-

0.5

Trade and other receivables

0.6

-

-

0.6

Cash and cash equivalents

0.1

-

-

0.1

Trade and other payables

(0.4)

-

-

(0.4)

Deferred tax liabilities

 

(0.8)

-

0.3

(0.5)

Net assets acquired

2.4

-

(0.6)

1.8

Goodwill

 

7.0

0.2

0.6

7.8

Total purchase price

9.4

0.2

-

9.6

Acquired cash and cash equivalents

(0.1)

-

-

(0.1)

Contingent consideration

 

(2.8)

-

-

(2.8)

Net cash outflow on acquisitions

 

6.5

0.2

-

6.7

 

Acquisitions in 2014

 

The aggregated fair values arising from the 2014 acquisitions are set out in the following table:

 

 

 

 

 

 

 

 

 

Notes

 

£m

 

Intangible assets (restated)

 

 

1

3.0

Property, plant and equipment

 

 

 

1.0

Trade and other receivables

 

 

 

1.6

Cash and cash equivalents

 

 

 

0.4

Trade and other payables

 

 

 

(1.0)

Income tax payable

 

 

 

(0.2)

Long-term provisions

 

 

 

(0.2)

Deferred tax liabilities (restated)

 

 

1

(0.8)

Net assets acquired

 

 

 

3.8

Goodwill (restated)

 

 

1

12.1

Total purchase price

 

 

 

15.9

Acquired cash and cash equivalents

 

 

 

(0.4)

Contingent consideration

 

 

 

(4.1)

Net cash outflow on acquisitions

 

 

 

11.4

 

 

9. BANK AND OTHER BORROWINGS

 

Amounts falling due in:

 

Amounts falling due in:

 

 

less than one year

more than one year

2015

Total

less than one year

more than one year

2014

Total

 

£m

£m

£m

£m

£m

£m

Term loans

-

169.7

169.7

-

173.5

173.5

Revolving credit facility

12.0

-

12.0

-

-

-

Bank overdrafts

0.1

-

0.1

-

-

-

Debt issue costs - term loans

-

(2.1)

(2.1)

-

(2.7)

(2.7)

Bank and other borrowings

12.1

167.6

179.7

-

170.8

170.8

Finance leases

0.1

0.3

0.4

0.2

0.3

0.5

 

12.2

167.9

180.1

0.2

171.1

171.3

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR UGUCUWUPQGMP

Related Shares:

EXO.L
FTSE 100 Latest
Value8,275.66
Change0.00